Treatment | Survival | Relative biomass | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 113 DAT | 211 DAT | 253 DAT | 113 DAT | 211 DAT | 253 DAT | ||||||
Group 1: most persistent | ||||||||||||
tric/pic | 0.0 | d | 30.7 | b | 53.0 | a | 0.0 | c | 13.9 | b | 14.5 | b |
hexa-H | 0.0 | d | 71.2 | ab | 86.5 | a | 0.0 | c | 63.4 | ab | 72.8 | a |
Group 2: intermediate persistence | ||||||||||||
hexa-L | 13.7 | cd | 90.5 | a | 93.2 | a | 7.2 | bc | 91.3 | a | 74.3 | a |
terbu/hexa | 15.6 | bcd | 85.7 | ab | 83.3 | a | 17.2 | bc | 64.4 | ab | 59.1 | a |
clopyr-H | 39.3 | abcd | 71.2 | ab | 86.7 | a | 36.8 | abc | 51.7 | ab | 65.2 | a |
clopyr-L | 54.3 | abcd | 90.5 | a | 86.0 | a | 31.1 | abc | 92.5 | a | 83.1 | a |
terbu-H | 65.2 | abc | 95.2 | a | 93.3 | a | 42.4 | abc | 67.2 | ab | 78.7 | a |
Group 3: least persistent | ||||||||||||
terbu-L | 77.9 | ab | 71.7 | ab | 86.5 | a | 71.2 | ab | 77.6 | a | 91.7 | a |
triclo | 79.7 | a | 88.1 | a | 88.9 | a | 49.7 | abc | 93.3 | a | 80.9 | a |
metsul-L | 81.0 | a | 88.1 | a | 97.6 | a | 85.7 | a | 90.8 | a | 91.2 | a |
metsul-H | 85.7 | a | 81.0 | ab | 85.9 | a | 68.9 | ab | 89.2 | a | 76.9 | a |
Significance of one-way ANOVA (F 10,32) | ||||||||||||
Treatment | 7.48*** | 2.68* | 1.50ns | 5.43*** | 4.51** | 6.41*** |